-
Lycopene, ERK, and DON-Induced Gut Barrier Injury
2026-09-02
The 2025 reference study identifies ERK signaling as a mechanistic link between deoxynivalenol-induced oxidative and inflammatory injury, intestinal barrier dysfunction, and NLRP3 inflammasome activation. In an IPEC-J2 cell model, lycopene reversed these changes, while pharmacological ERK activation weakened the protection, supporting ERK as a candidate target for further mycotoxin-toxicity research.
-
Q-VD-OPh: Reading Apoptosis Beyond Caspase Assays
2026-09-02
Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can help separate mitochondrial apoptosis initiation from downstream execution. This mechanistic guide connects BAX–BAK pore biology with assay design, cell viability workflows, and Alzheimer’s disease research.
-
5-Azacytidine Workflows for Leukemia Epigenetics
2026-09-01
Build reproducible DNA methylation experiments with 5-Azacytidine, from concentration-finding and gene-reactivation assays to leukemia-focused mechanism studies. Its value is greatest as a DNMT benchmark that can distinguish epigenetic effects from the dual tubulin–DNMT activity reported for the novel compound H62.
-
Reactive Oxygen Species Assay Kit for Mitophagy
2026-09-01
Learn how the Reactive Oxygen Species Assay Kit and dihydroethidium (DHE) probe can connect intracellular superoxide measurement with mitophagy and pulmonary fibrosis research. This guide emphasizes mechanism-driven assay design, controls, interpretation, and the limitations of fluorescence-based ROS analysis.
-
Annexin V-PE Reagent for CD38 CAR-T Assays
2026-08-31
Use Annexin V-PE Reagent to convert phosphatidylserine exposure into a rapid readout of target-cell killing, CAR-T fratricide, and assay-state transitions. The workflow pairs early apoptosis marker detection with structure-guided CD38 binder comparisons, adding kinetic and mechanistic resolution beyond a single viability endpoint.
-
Carfilzomib Sensitizes ESCC to Iodine-125 Radiation
2026-08-31
A 2025 Translational Oncology study shows that carfilzomib strengthens iodine-125 seed radiation against esophageal squamous cell carcinoma by intensifying endoplasmic reticulum stress and engaging apoptosis, paraptosis, and ferroptosis. The work provides a mechanistic framework for overcoming brachytherapy resistance, while also identifying the need to distinguish overlapping cell-death pathways experimentally.
-
ICAA Targets RIP3 in Cardiac Hypertrophy
2026-08-30
The reference study identifies isochlorogenic acid A (ICAA) as a protective compound that directly targets RIP3 and suppresses downstream CaMKII signaling in angiotensin II- and pressure overload-induced cardiac hypertrophy. Its most important mechanistic advance is showing that RIP3 can regulate hypertrophy independently of the canonical MLKL pathway, providing a distinct framework for cardiovascular disease research.
-
Biomimetic Nanoplatform for Metastatic TNBC
2026-08-29
This ACS Nano study developed a biomimetic nanoplatform that combines photothermal tumor ablation with immune remodeling to address metastatic triple-negative breast cancer. Its coordinated use of homologous tumor targeting, stimulus-responsive drug release, tumor vaccination, and T-cell activation offers a preclinical framework for treating both primary tumors and systemic recurrence.
-
Sodium Ascorbate in Cancer Research
2026-08-28
Sodium Ascorbate is a mineral salt of ascorbic acid used to study oxidative-stress-driven cancer cell injury. This article connects its ROS-based preclinical profile with biomarker-aware assay design, showing how GPNMB research can sharpen—not overstate—translational interpretation.
-
5-Azacytidine Triggers DNA Damage in Myeloma Cells
2026-08-28
The reference study showed that 5-Azacytidine kills therapy-sensitive and therapy-resistant multiple myeloma cells through ATR-associated DNA double-strand break responses and both caspase-dependent and caspase-independent apoptosis. Its synergistic activity with doxorubicin and bortezomib provides a preclinical rationale for combination studies while highlighting the need to distinguish DNA demethylation from DNA damage as mechanisms of action.
-
Sodium Citrate in 3D SERS Workflows
2026-08-27
Sodium citrate is a water-soluble biochemical research reagent that combines buffering capacity with metal-ion chelation. In 3D SERS workflows, it is best treated as a controlled optimization variable rather than as a demonstrated cause of the performance reported for polymer-pen-lithography gold nanocluster arrays.
-
Peptide Tagging of P. aeruginosa Phage GV
2026-08-27
The reference study identified a conserved peptide motif that binds specifically to the Good Vibes lytic phage infecting Pseudomonas aeruginosa. By coupling the peptide to biotin or Cy5, the authors created an affinity-labeling strategy for phage detection and tracking that could complement direct particle labeling in future phage-therapy studies.
-
Dacomitinib (PF-00299804) in Cell Assays
2026-08-26
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in viability, proliferation, cytotoxicity, and signaling experiments. It addresses dosing, solvent compatibility, interpretation, and vendor-selection decisions with product-linked potency and handling data.
-
WIP1–p38 Signaling in Septic Acute Kidney Injury
2026-08-26
The reference study identifies WIP1/PPM1D as a brake on p38 MAPK-driven pyroptosis in sepsis-associated acute kidney injury. By integrating single-cell transcriptomics, human tissue analysis, HK2 cell experiments, and an LPS-induced mouse model, it shows that pharmacological PPM1D inhibition intensifies renal tubular inflammatory injury.
-
From Gut–Brain Mechanisms to Better Cy3 Imaging
2026-08-25
The paeoniflorin study connects alcohol-induced depressive-like behavior with gut dysbiosis, altered metabolites, microglial activation, and NF-κB/NLRP3 signaling. This thought-leadership guide shows how a Cy3-conjugated secondary antibody can help translational researchers convert that mechanistic model into spatially resolved, reproducible tissue evidence.